Research Article
Expression of Myeloid Antigen in Neoplastic Plasma Cells Is Related to Adverse Prognosis in Patients with Multiple Myeloma
Table 3
Multivariate regression analysis of factors significantly associated with PFS and OS.
| Variables | PFS | OS | HR | 95% CI | | HR | 95% CI | |
| CD13+ | 3.46 | 0.8–14.8 | 0.093 | 2.77 | 0.4–17.7 | 0.283 | CD33+ | 3.86 | 1.1–13.7 | 0.037 | 13.8 | 3.1–61.3 | 0.001 | β2-Microglobulin > 3.5 mg/dL | 6.93 | 2.0–24.1 | 0.002 | 4.02 | 1.0–16.7 | 0.055 | LDH > 202 U/L | 1.84 | 0.5–6.9 | 0.370 | 2.88 | 0.6–14.2 | 0.195 | Age ≥ 65 years | 0.40 | 1.1–0.1 | 0.076 | 1.50 | 0.5–4.6 | 0.481 | t(4;14) | 0.51 | 0.1–2.2 | 0.368 | 1.21 | 0.2–6.4 | 0.823 |
|
|
PFS: progression free survival; OS: overall survival; HR: hazard ratio; CI: confidence interval.
|